XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net income (loss) including non-controlling interests $ 9,845 $ 2,156 $ (9,138)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 737 823 947
Bad debt expense 61 92 114
Stock-based compensation 1,796 1,935 1,793
Loss from sale of investments 0 74 0
Gain on business divestitures 0 (204) (14)
Deferred income taxes (6,027) 26 (441)
Accretion of discounts on marketable debt securities, net (251) (154) (9)
Impairments of goodwill, long-lived assets and other assets 0 86 28
Impairment of equity method investment 0 0 182
Loss (income) from equity method investments, net 38 (48) (107)
Unrealized (gain) loss on debt and equity securities, net (1,832) (1,610) 7,045
Revaluation of MLU B.V. call option 0 0 (191)
Unrealized foreign currency transactions 308 138 96
Other 88 106 2
Change in assets and liabilities, net of impact of business acquisitions and disposals:      
Accounts receivable (142) (758) (542)
Prepaid expenses and other assets (694) (1,462) (196)
Operating lease right-of-use assets 196 191 193
Accounts payable 86 64 (133)
Accrued insurance reserves 2,819 2,230 730
Accrued expenses and other liabilities 330 80 498
Operating lease liabilities (221) (180) (215)
Net cash provided by operating activities 7,137 3,585 642
Cash flows from investing activities      
Purchases of property and equipment (242) (223) (252)
Purchases of non-marketable equity securities (289) (52) (14)
Purchases of marketable securities (12,765) (8,774) (1,708)
Proceeds from maturities and sales of marketable securities 10,204 5,069 376
Proceeds from sale of equity method investments 17 721 0
Proceeds from business divestiture 0 0 26
Acquisition of businesses, net of cash acquired 0 0 (59)
Other investing activities (102) 33 (6)
Net cash used in investing activities (3,177) (3,226) (1,637)
Cash flows from financing activities      
Proceeds from issuance and sale of subsidiary stock units 0 0 255
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan 156 130 92
Issuance of term loan and notes, net of issuance costs 3,972 2,824 0
Purchase of Capped Calls 0 (141) 0
Principal repayment on term loan and notes (3,986) (2,675) 0
Principal repayment on Careem Notes 0 (25) (80)
Principal payments on finance leases (172) (171) (184)
Repurchases of common stock (1,252) 0 0
Redemption of non-controlling interests (851) 0 0
Other financing activities 46 (37) (68)
Net cash provided by (used in) financing activities (2,087) (95) 15
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents (267) 63 (148)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents 1,606 327 (1,128)
Cash and cash equivalents, and restricted cash and cash equivalents      
Beginning of period 7,004 6,677 7,805
End of period 8,610 7,004 6,677
Cash paid for:      
Interest, net of amount capitalized 475 629 513
Income taxes, net of refunds 324 234 175
Non-cash investing and financing activities:      
Finance lease obligations 4 216 349
Right-of-use assets obtained in exchange for lease obligations 132 84 329
Ownership interest received in exchange for divestitures $ 0 $ 300 $ 0